China Pharma Holdings - Stock Split History | CPHI
Stock split history for China Pharma Holdings since 2019. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
| China Pharma Holdings Annual Stock Splits |
|---|
| China Pharma Holdings Quarterly Stock Splits |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.010B | $0.012B |
| CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allergan (AGN) | Ireland | $61.086B | 11.14 |
| Teva Pharmaceutical Industries (TEVA) | Israel | $10.724B | 4.36 |
| Bausch Health Cos (BHC) | Canada | $10.203B | 6.73 |
| Mylan (MYL) | United States | $9.755B | 4.38 |
| Dr Reddy's Laboratories (RDY) | India | $6.645B | 17.43 |
| ASPEN PHARMACR (APNHY) | South Africa | $3.470B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $1.152B | 11.15 |
| Amphastar Pharmaceuticals (AMPH) | United States | $0.893B | 46.42 |
| Homology Medicines (FIXX) | United States | $0.783B | 0.00 |
| Voyager Therapeutics (VYGR) | United States | $0.509B | 0.00 |
| Akorn (AKRX) | United States | $0.462B | 0.00 |
| Progenics Pharmaceuticals (PGNX) | United States | $0.431B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.417B | 0.00 |
| Mallinckrodt Public (MNK) | United Kingdom | $0.284B | 0.39 |
| Adamas Pharmaceuticals (ADMS) | United States | $0.182B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.170B | 0.00 |
| Zynerba Pharmaceuticals (ZYNE) | United States | $0.131B | 0.00 |
| CymaBay Therapeutics (CBAY) | United States | $0.114B | 0.00 |
| Teligent (TLGT) | United States | $0.034B | 0.00 |
